Modelling the Human Blood-Brain Barrier in Huntington Disease

While blood-brain barrier (BBB) dysfunction has been described in neurological disorders, including Huntington's disease (HD), it is not known if endothelial cells themselves are functionally compromised when promoting BBB dysfunction. Furthermore, the underlying mechanisms of BBB dysfunction remain elusive given the limitations with mouse models and post mortem tissue to identify primary deficits. We established models of BBB and undertook a transcriptome and functional analysis of human induced pluripotent stem cell (iPSC)-derived brain-like microvascular endothelial cells (iBMEC) from HD patients or unaffected controls. We demonstrated that HD-iBMECs have abnormalities in barrier properties, as well as in specific BBB functions such as receptor-mediated transcytosis.

Automated summary

This study investigated the abnormalities and underlying mechanisms of blood-brain barrier (BBB) dysfunction in Huntington's disease using a model of human induced pluripotent stem cell-derived brain-like microvascular endothelial cells (iBMECs). The findings suggest that HD-iBMECs have abnormalities in barrier properties and specific BBB functions.